Vitronectin- and fibronectin-containing immune complexes in primary systemic vasculitis.

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Anti-endothelial cell autoantibodies (AECA) are frequently observed in primary systemic vasculitis.
• The specific antigens targeted by these AECA remain largely unidentified, hindering understanding of disease mechanisms.

Purpose of the Study:

• To identify the antigens targeted by AECA in patients with vasculitis.
• To investigate the presence and characteristics of immune complexes (IC) involving endothelial cells in Churg Strauss Syndrome (CSS) and Wegener's Granulomatosis (WG).

Main Methods:

• Utilized a co-operative binding assay with monoclonal antibodies (mAb) against human umbilical vein endothelial cells (HUVEC) and extracellular matrix proteins.
• Measured human antibody binding to endothelial cell lysates incubated with mAb targeting Vitronectin (VN) and Fibronectin (FN).
• Assessed the presence of free autoantibodies and the effect of endothelial cell lysate on patient serum antibody binding.

Main Results:

• Antibody binding was enhanced in sera from CSS and WG patients when using mAb against VN and FN.
• No free autoantibodies against VN or FN were detected; endothelial cell lysate did not alter patient serum antibody binding.
• Preformed VN and FN-containing immune complexes (IC) were identified in patient sera and shown to bind to HUVEC.

Conclusions:

• Patients with CSS and WG possess preformed immune complexes containing VN and FN in their sera.
• These VN and FN-containing IC exhibit binding affinity for endothelial cells.
• While these IC bind to endothelial cells, their precise role in the pathogenesis of vasculitis requires further investigation.